Covid-19: Vaccine Trials Of Johnson & Johnson Paused Following 'Unexplained' Illness In Participant

Covid -19 vaccine trials of the American multinational company Johnson & Johnson have been temporarily paused after a participant fell ill.

(Representative Image/ Getty)

New Delhi: The American multinational company Johnson & Johnson has temporarily paused its Covid 19 vaccine trial after a participant fell ill. The company informed on Monday that they have halted their phase 3 trial of the vaccine that is being developed by its Janssen Pharmaceutical Companies. "We have temporarily paused further dosing in all our Covid-19 vaccine candidate clinical trials, including the  Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant," the company said in a statement. According to a Reuters report, the company said that such pauses are normal in big trials. It said the “study pause” in giving doses of the vaccine candidate was different from a “regulatory hold” required by health authorities. The current case is a pause. The company has not given details on the illness. The company began its large-scale, multi-country Phase 3 trial for its vaccine candidate, JNJ-78436735 last month after Phase 1 and Phase 2 trials showed positive results. Last month, the British-Swedish biopharmaceutical giant AstraZeneca had also put a hold on its ongoing late-stage trials of Covid 19 vaccine after a participant developed a serious reaction to it. A news report by PTI said that trials have been paused until the company determines if the ‘potentially unexplained’ illness is a side effect of the vaccine. It was resumed following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so.